Continuous 24-hour GHRP-2 infusion in women activated the GH axis through three distinct mechanisms — pituitary, hypothalamic GHRH amplification, and somatostatin suppression — revealing complex neuroregulation.
3 pathwaysGHRP-2 works through direct pituitary, GHRH amplification, and somatostatin suppression mechanisms simultaneously in women
What the researchers found
GHRP-2 activates the female GH axis through three mechanisms: direct pituitary somatotroph stimulation, amplification of endogenous GHRH release, and functional somatostatin withdrawal, explaining its synergy with GHRH.
Why it matters
Understanding the tripartite mechanism explains why GH secretagogues are so effective and how they differ from GHRH alone. This knowledge is essential for optimizing GH secretagogue therapy in women, who have distinct GH dynamics.
How the study worked
Clinical trial in women using continuous 24-hour IV GHRP-2 infusion combined with GHRH co-administration and pharmacological somatostatin pathway blocking. GH profiles sampled every 10 minutes for deconvolution analysis.
What this study cannot tell us
Relatively invasive protocol (24-hour IV infusion with frequent blood sampling). Small sample size typical for such intensive studies. Acute infusion may not reflect chronic dosing dynamics.
How to read the evidence
Moderate evidence from a detailed mechanistic clinical study with intensive hormonal profiling, limited by small sample size and acute design.
When this study was published
Published in 1999. The tripartite GHRP mechanism has been confirmed and extended to understanding ghrelin's central effects.
The bigger picture
GH regulation differs between men and women. This detailed mechanistic study in women provides sex-specific understanding essential for developing personalized GH secretagogue therapy.
Questions still open
- Does the tripartite mechanism also apply to oral GH secretagogues?
- Which mechanism is most important for sustained GH release?
- Do the three pathways respond differently in aging women?
Common questions
How does GHRP-2 release growth hormone?
Is GH regulation different in women?
Read the original research
Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.
The Journal of clinical endocrinology and metabolism, 84(6), 2140-50
Citation
Shah, N; Evans, W S; Bowers, C Y; Veldhuis, J D. (1999). Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.. The Journal of clinical endocrinology and metabolism, 84(6), 2140-50.